Greener Journal of Epidemiology and Public Health Vol. 3 (2), pp. 022-027, November 2015.
ISSN: 2354-2381 © 2015 Greener Journals
Manuscript Number: 112315162
Knowledge, attitudes and use of generic medicines: a cross sectional study among patients in Marcory-Treichville Health District Cote d’Ivoire
Sagou Patrick Olivier Yayo1,2, Kadidiatou Raissa Kourouma2*, Johanna Francisca Attissou1, Orphée Kouakou1,
Salimata Dagnoko1 and Eulalie Oga1
1 Programme National de Développement de l’Activité Pharmaceutique (PNDAP), Address 18 BP 2665 Abidjan 18 Cote d’Ivoire
2 Institut National de Santé Publique INSP, Address BPV 47 Abidjan Cote d’Ivoire
Background: The regulation of generic medicines is a policy adopted in order to reduce pharmaceutical cost in many countries and Cote d’Ivoire is no exception. However, the acceptance of generics depend on people’s beliefs that is why we conducted a study notably in order to assess the level of knowledge, attitude and usage profile for generic medicine among patients in Cote d’Ivoire.
Methods: A cross-sectional study was conducted with 320 patients (210 women and 110 men, aged 35.1±11.3 years) selected at random in four health facilities of Marcory-Treichville Health District. A questionnaire was drawn up with questions on their knowledge, attitude and use, perceptions and knowledge of generic medicines. All the collected data were entered into PASW®18.0 for descriptive analysis.
Results: Half of the participants (55.6%) knew that generic medicines exist, but only 56.2% were able to define them correctly. These information sources were mainly through television (28.1%), followed by doctors (21.4%), word of mouth (20.2%). Regarding generic medicines characteristics, 88.2% declared that they were confident about their efficacy and quality, 75.3% believed that generic medicines have the same effect as branded medicines, 72.5% said that generics were priced lower than branded medicines, and 65.2% stated that if their doctor prescribed a branded medicine and the pharmacist proposed them a cheaper generic, they would agree to switch. With regard to medicines prescribed by medical practitioners, 80.4% said that their doctors often prescribed generics; 12.5% confirmed that their doctors always prescribed generics and 7.1% that they "never".
Conclusion: These findings suggest that more awareness should be created among health professionals to boost generic medicine prescriptions and substitution, and also among patients by education program.
Key words: Reference medicine; Generic medicine; Health policy; pharmaceutical policy; Patient education.
Al-Gedadi NA, Hassali MA, and Shafie AA (2008). A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia Pharm Pract (Granada). 2008 ; 6(2): 93–97.
Blatt CR, Trauthman SC, Schmidt EH, Marchesan S, Da Silva LM and Martins JL (2012). General awareness and use of generic medication among citizens of Tubarão, state of Santa Catarina, Brazil. Cien Saude Colet. 17(1):79-87.
Birkett DJ (2003): Generics – equal or not? Aust Prescr. 26(4):85–87.
Dylst P, Vulto A and Simoens S (2013). Demand-side policies to encourage the use of generic medicines: an overview. Expert Rev Pharmacoecon Outcomes Res. 13(1):59–72.
Hassali MA, Kong DCM and Stewart K (2005). Generic medicines: perceptions of consumers in Melbourne, Australia. Int J Pharm Pract. 13:257–64.
Kanavos P (1999). Financing pharmaceuticals in transition economies. Croat Med J. 40:244-259.
Karim S, Pillai G, Ziqubu-Page TT, Cassimjee MH and Morar MS (1996). Potential savings from generic prescribing and generic substitution in South Africa. Health Policy Plan. 11: 198-205.
King DR and Kanavos P (2002). Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 43(4): 462–469.
Lira CA, Oliveira JN, Andrade MS, Vancini-Campanharo CR and Vancini RL (2014). Knowledge, perceptions and use of generic drugs: a cross sectional study .Einstein. 12(3):267-73.
National Program of Pharmaceutical Activities Development Cote d’Ivoire (2015). National Pharmaceutical Policy. [Last accessed on 2015 Oct 12]. Available from: http://www.pndap-ci.org//monrepertoire/PPN/index.html.
Palagyi M and Lassanova M (2008). Patients attitudes towards experience with use of generics in Slovakia, performance of generic substitution. Bratisl Lek Listy. 109(7):324–8.
Ringuier R, Rouquette A, Dagorne C, Garnier F and Fanello S (2008). Connaissance et perceptions des médicaments génériques après 50 ans. Thérapie. 63 (1): 11–17.
Savadogo LGB, Sondo B, Guissou IP, Kouanda S and Dujardin B (2002). Utilisation des médicaments essentiels génériques par le personnel hospitalier : le cas du CHU Yalgado Ouédraogo (Burkina Faso). Cahiers d'études et de recherches francophones / Santé. 12(2):257-62.
Thomas R and Vitry A (2009). Consumers’ perception of generic medicines in community pharmacies in Malaysia. South Med Rev. 2 (2):20-3.
Valles JA, Bareiro M, Cerera G, G, Ferro JJ, Martínez MJ, Escribà JM, Iglesias B, Cucurull E, and Barceló E (2003). A prospective multicenter study of the effect of patient education on acceptibility of generic prescribing in general practice. Health Policy .65(3): 269-75.
Wong ZY, Hassali MA, Alrasheedy AA, Saleem F, Yahaya AH and Aljadhey H. (2014). Patients’ beliefs about generic medicines in Malaysia. Pharma Pract, 12(4), 474.
World Health Organization (2015). Generic Drugs. [Last accessed on 2015 Oct 12] Available from http://www.who.int/trade/glossary/story034/en/index.html.
Zaoui S, Hakkou F and Filali H (2011). Le médicament générique au Maroc: enquête auprès des médecins. Thérapie. 66 (6): 499-506.
Zaoui, S, Hakkou, F, Filali, H, Khabal Y, Tazi I and Mahmal L (2013). Le médicament générique au Maroc: le point de vue du consommateur. The Pan Afr Med Journal. 15:18.